Artivion Inc (AORT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Artivion Inc (AORT) has a cash flow conversion efficiency ratio of 0.003x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.15 Million) by net assets ($450.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AORT market cap for the company's overall valuation and market capitalisation.
Artivion Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Artivion Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Artivion Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Artivion Inc ranked by their cash flow conversion efficiency. Explore AORT operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Jinqiao Export Processing Zone Development Co Ltd A
SHG:600639
|
0.007x |
|
Huizhou Speed Wireless Technology Co Ltd
SHE:300322
|
-0.085x |
|
Guangdong CHJ Industry Co Ltd
SHE:002345
|
-0.164x |
|
Malaysia Building Society Bhd
KLSE:1171
|
0.025x |
|
Nantong Jiangshan Agrochemical & Chemicals Co Ltd
SHG:600389
|
0.047x |
|
Celltrion Pharm Inc
KQ:068760
|
0.055x |
|
North China Pharmaceutical Co Ltd
SHG:600812
|
0.025x |
|
Palfinger AG
VI:PAL
|
0.003x |
Annual Cash Flow Conversion Efficiency for Artivion Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Artivion Inc from 1991 to 2025. View AORT stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $448.23 Million | $38.13 Million | 0.085x | +5.66% |
| 2024-12-31 | $276.20 Million | $22.24 Million | 0.081x | +20.51% |
| 2023-12-31 | $281.78 Million | $18.82 Million | 0.067x | +468.63% |
| 2022-12-31 | $284.33 Million | $-5.15 Million | -0.018x | -110.84% |
| 2021-12-31 | $300.73 Million | $-2.58 Million | -0.009x | -122.84% |
| 2020-12-31 | $328.71 Million | $12.37 Million | 0.038x | -32.08% |
| 2019-12-31 | $285.70 Million | $15.83 Million | 0.055x | +54.22% |
| 2018-12-31 | $275.07 Million | $9.88 Million | 0.036x | -7.22% |
| 2017-12-31 | $279.04 Million | $10.80 Million | 0.039x | -58.97% |
| 2016-12-31 | $208.98 Million | $19.72 Million | 0.094x | +28.03% |
| 2015-12-31 | $155.25 Million | $11.44 Million | 0.074x | +34.99% |
| 2014-12-31 | $148.69 Million | $8.12 Million | 0.055x | -52.88% |
| 2013-12-31 | $144.75 Million | $16.77 Million | 0.116x | -21.83% |
| 2012-12-31 | $128.11 Million | $18.99 Million | 0.148x | +7.55% |
| 2011-12-31 | $121.54 Million | $16.75 Million | 0.138x | -24.63% |
| 2010-12-31 | $113.94 Million | $20.84 Million | 0.183x | +21.88% |
| 2009-12-31 | $110.45 Million | $16.57 Million | 0.150x | +56.27% |
| 2008-12-31 | $99.33 Million | $9.54 Million | 0.096x | -35.29% |
| 2007-12-31 | $62.63 Million | $9.29 Million | 0.148x | +821.60% |
| 2006-12-31 | $52.09 Million | $-1.07 Million | -0.021x | +94.38% |
| 2005-12-31 | $50.62 Million | $-18.52 Million | -0.366x | -11.95% |
| 2004-12-31 | $49.66 Million | $-16.23 Million | -0.327x | -166.25% |
| 2003-12-31 | $48.34 Million | $-5.93 Million | -0.123x | -363.90% |
| 2002-12-31 | $79.80 Million | $-2.11 Million | -0.026x | -141.42% |
| 2001-12-31 | $101.44 Million | $6.48 Million | 0.064x | -44.45% |
| 2000-12-31 | $89.39 Million | $10.28 Million | 0.115x | +834.62% |
| 1999-12-31 | $80.23 Million | $987.00K | 0.012x | -17.57% |
| 1998-12-31 | $80.40 Million | $1.20 Million | 0.015x | +120.49% |
| 1997-12-31 | $30.20 Million | $-2.20 Million | -0.073x | -145.35% |
| 1996-12-31 | $24.90 Million | $4.00 Million | 0.161x | +199.38% |
| 1995-12-31 | $20.50 Million | $1.10 Million | 0.054x | -63.06% |
| 1994-12-31 | $17.90 Million | $2.60 Million | 0.145x | +220.56% |
| 1993-12-31 | $16.60 Million | $-2.00 Million | -0.120x | +65.43% |
| 1991-12-31 | $6.60 Million | $-2.30 Million | -0.348x | -- |
About Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid… Read more